US EditionAbbVie to Invest $380 Million to Expand US Manufacturing in Illinois
The $380 million investment will create 300 jobs and expand manufacturing of active pharmaceutical ingredients for neuroscience and obesity drugs, supported by state tax credits.
- In spring 2026, AbbVie, the North Chicago–based biopharmaceutical company, announced it will invest $380 million to build two manufacturing facilities, with operations expected by 2029.
- In exchange for tariff and price exemptions, the projects help fulfill an agreement AbbVie made with the Trump administration earlier this year and enroll in Illinois' EDGE program, providing tax credits over 15 years.
- The two plants will produce active pharmaceutical ingredients to support neuroscience and obesity medications, creating about 300 new jobs including engineers, scientists, manufacturing operators and lab technicians at the North Chicago site.
- As part of broader U.S. moves, AbbVie is expanding beyond Illinois by acquiring an Arizona facility and investing at a Massachusetts site, with more U.S. investments expected in 2026.
- Adding to that, the projects join a previously announced $195 million North Chicago facility and follow last year's ground-breaking as AbbVie expands API manufacturing and employs about 29,000 U.S. workers, including more than 6,000 at manufacturing sites.
17 Articles
17 Articles
Governor Pritzker Announces Major AbbVie Manufacturing Expansion
NORTH CHICAGO - Governor JB Pritzker, the Illinois Department of Commerce and Economic Opportunity (DCEO), and the Illinois Economic Development Corporation (Illinois EDC) announced today that AbbVie will construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago location, investing $380 million and creating 300 new full-time jobs. This new investment underscores Illinois’ robust and rapidly expanding …
North Chicago-based AbbVie investing $380 million on new pharmaceutical plants
Global drugmaker AbbVie will invest $380 million to build two new manufacturing facilities at its North Chicago campus, the company said on Monday.The plants will make active pharmaceutical ingredients for AbbVie’s obesity and neuroscience medications. They will create at least 300 full-time jobs, including roles for engineers, scientists, manufacturing operators and lab technicians.Construction will start this spring, with the facilities openin…
AbbVie to build 2 new manufacturing facilities at North Chicago headquarters, company and Gov. Pritzker announce
AbbVie will build two new active pharmaceutical ingredient manufacturing facilities at its North Chicago headquarters over the next three years, investing $380 million and creating 300 new full-time jobs, the company and Gov. JB Pritzker announced Monday in a pair of news releases.
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
